Mediphage Bioceuticals Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mediphage Bioceuticals's estimated annual revenue is currently $4M per year.(i)
  • Mediphage Bioceuticals's estimated revenue per employee is $155,000

Employee Data

  • Mediphage Bioceuticals has 26 Employees.(i)
  • Mediphage Bioceuticals grew their employee count by -4% last year.

Mediphage Bioceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
EVP Research & DevelopmentReveal Email/Phone
5
EVP Research & DevelopmentReveal Email/Phone
6
Chief Scientific OfficerReveal Email/Phone
7
Manufacturing Process SpecialistReveal Email/Phone
8
Senior Scientist - Manufacturing and Process DevelopmentReveal Email/Phone
9
Associate ScientistReveal Email/Phone
10
Process Development SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M9-72%$39.4MN/A
#2
$0.9M11-83%$23.8MN/A
#3
$87.6M5656%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$7.8M50-68%N/AN/A
#6
$13.5M8730%N/AN/A
#7
$17.8M115-6%N/AN/A
#8
$0.9M11-39%N/AN/A
#9
$13.6M88-20%$86MN/A
#10
$20M129-12%N/AN/A
Add Company

What Is Mediphage Bioceuticals?

Mediphage Bioceuticals is a non-viral gene therapy company focused on developing safe, effective and durable gene therapies for patients worldwide. Our flagship technology, ministring DNA, is a novel form of non-viral transgene delivery that achieves safety, redosability, and efficient and scalable manufacturing. Currently, Mediphage Bioceuticals is focusing its in-house efforts on applying ministring DNA as a therapeutic solution for Stargardt Disease and a COVID-19 DNA vaccine.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mediphage Bioceuticals News

2022-03-30 - TEDxToronto Announces 2022 Speaker Slate

Nafiseh Nafissi is a top scientist and Molecular/Microbiologist in Canada. She is the Executive VP of R&D at Mediphage Bioceuticals, and the co-...

2022-03-30 - TEDxToronto Announces 2022 Speaker Slate

Nafiseh Nafissi is a top scientist and Molecular/Microbiologist in Canada. She is the Executive VP of R&D at Mediphage Bioceuticals, and the co-...

2022-03-22 - The Cell and Gene Therapy Bioassay Services Market worth ...

In Dec 2021, Mediphage Bioceuticals, Inc. has been acquired by CCRM Enterprises Inc., the company's venture capital arm.

2022-03-22 - The Cell and Gene Therapy Bioassay Services Market worth ...

In Dec 2021, Mediphage Bioceuticals, Inc. has been acquired by CCRM Enterprises Inc., the company's venture capital arm.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M260%N/A
#2
$2.5M26-28%N/A
#3
$1.7M26-19%$60M
#4
$2.5M26N/AN/A
#5
$4M26N/AN/A